I agree that this site is using cookies. You can find further informations here.
X
Tompson, Debra J
37  results:
Search for persons X
?
1

Inhibition of Receptor-Interacting Protein Kinase 1 in Chro..:

Ludbrook, Valerie J. ; Budd, David C. ; Thorn, Katie...
Dermatology and Therapy.  14 (2024)  2 - p. 489-504 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Longitudinal modeling of efficacy response in patients with..:

Simeoni, Monica ; Yang, Shuying ; Tompson, Debra J..
Journal of Pharmacokinetics and Pharmacodynamics.  51 (2024)  3 - p. 289-301 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Physiologically based pharmacokinetic modeling for developm..:

Salem, Farzaneh ; Nimavardi, Ali ; Mudunuru, Jennypher...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  6 - p. 808-820 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Development of a Once-Daily Modified-Release Formulation fo..:

Tompson, Debra ; Whitaker, Mark ; Pan, Rennan...
Pharmaceutical Research.  39 (2022)  1 - p. 153-165 , 2022
Link: https://doi.org/10.1007/..
 
?
5

A randomised, placebo-controlled study of RIPK1 inhibitor G..:

Weisel, Kathy ; Scott, Nicola ; Berger, Scott...
BMJ Open Gastroenterology.  8 (2021)  1 - p. e000680 , 2021
Link: https://doi.org/10.1136/..
 
?
6

A randomized, placebo-controlled experimental medicine stud..:

Weisel, Kathleen ; Berger, Scott ; Thorn, Katie...
Arthritis Research & Therapy.  23 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
7

Development of a Prototype, Once-Daily, Modified-Release Fo..:

Tompson, Debra J. ; Whitaker, Mark ; Pan, Rennan...
Pharmaceutical Research.  38 (2021)  7 - p. 1235-1245 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Response to Inhibition of Receptor‐Interacting Protein Kina..:

Weisel, Kathleen ; Berger, Scott ; Papp, Kim...
Clinical Pharmacology & Therapeutics.  108 (2020)  4 - p. 808-816 , 2020
Link: https://doi.org/10.1002/..
 
?
9

Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK29..:

Tompson, Debra J. ; Davies, Carwyn ; Scott, Nicola E....
European Journal of Drug Metabolism and Pharmacokinetics.  46 (2020)  1 - p. 71-83 , 2020
Link: https://doi.org/10.1007/..
 
?
10

Randomized clinical study of safety, pharmacokinetics, and ..:

Weisel, Kathleen ; Scott, Nicola E. ; Tompson, Debra J....
Pharmacology Research & Perspectives.  5 (2017)  6 - p. , 2017
Link: https://doi.org/10.1002/..
 
?
11

Lesion remyelinating activity of GSK239512 versus placebo i..:

Schwartzbach, Caryl J. ; Grove, Richard A. ; Brown, Robert...
Journal of Neurology.  264 (2016)  2 - p. 304-315 , 2016
Link: https://doi.org/10.1007/..
 
?
12

Single and Multiple Dose Pharmacokinetics, Pharmacodynamics..:

Hu, Chaoying ; Tompson, Debra ; Magee, Mindy...
PLOS ONE.  10 (2015)  10 - p. e0139862 , 2015
Link: https://doi.org/10.1371/..
 
?
13

A novel design for a dose finding, safety, and drug interac..:

Sachdeo, Rajesh ; Partiot, Arnaud ; Biton, Victor...
Int. Journal of Clinical Pharmacology and Therapeutics.  52 (2014)  6 - p. 509-518 , 2014
Link: https://doi.org/10.5414/..
 
?
14

Lack of effect of ezogabine/retigabine on the pharmacokinet..:

Tompson, Debra ; Crean, Christopher ; Buraglio, Mauro.
Clinical Pharmacology: Advances and Applications.  , 2014
Link: https://doi.org/10.2147/..
 
?
15

The Effects of Ethanol on the Pharmacokinetics, Pharmacodyn..:

Crean, Christopher S. ; Tompson, Debra J.
Clinical Therapeutics.  35 (2013)  1 - p. 87-93 , 2013
Link: https://doi.org/10.1016/..
 
1-15